Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Pediatrics|January 26, 2025
Prescription Stimulant Dispensing to US Children: 2017-2023Sijia He, Sean Esteban McCabe, Rena M Conti, et al.
Medical Care|November 20, 2004
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depressionJulie M Donohue, Ernst R Berndt, Meredith Rosenthal, et al.
Managed Care Interface|June 29, 2002
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxietyGeorge J Wan, William H Crown, Ernst R Berndt, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug DevelopmentLynn G Baird, Mark R Trusheim, Hans-Georg Eichler, et al.
Pharmacoeconomics|June 20, 2008
Generic entry, reformulations and promotion of SSRIs in the USHaiden A Huskamp, Julie M Donohue, Catherine Koss, et al.
Archives of Internal Medicine|January 13, 2010
Impact of FDA black box advisory on antipsychotic medication useE Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.
Pharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 7, 2019
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017Alice J Chen, Xiaohan Hu, Rena M Conti, et al.
Research in Social & Administrative Pharmacy : RSAP|November 22, 2020
60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroadT Joseph Mattingly, Dominique Seo, Adam M Ostrovsky, et al.
Pediatrics|December 13, 2016
Use of Low-Value Pediatric Services Among the Commercially InsuredKao-Ping Chua, Aaron L Schwartz, Anna Volerman, et al.
Pageof 14